Abstract
Dopamine participates in multiple sclerosis (MS) pathogenesis by modulating immune cell activity. This study aimed to clarify the role of dopaminergic receptors in dopamine-mediated modulation of Th17-cells in MS.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
